89 related articles for article (PubMed ID: 20178080)
1. Clinical experience in managing pediatric patients with ultra-short bowel syndrome using omega-3 fatty acid.
Chung PH; Wong KK; Wong RM; Tsoi NS; Chan KL; Tam PK
Eur J Pediatr Surg; 2010 Mar; 20(2):139-42. PubMed ID: 20178080
[TBL] [Abstract][Full Text] [Related]
2. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome.
Diamond IR; Sterescu A; Pencharz PB; Kim JH; Wales PW
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):209-15. PubMed ID: 19179884
[TBL] [Abstract][Full Text] [Related]
3. What is the current role for parenteral lipid emulsions containing omega-3 fatty acids in infants with short bowel syndrome?
Diamond IR; Pencharz PB; Wales PW
Minerva Pediatr; 2009 Jun; 61(3):263-72. PubMed ID: 19461570
[TBL] [Abstract][Full Text] [Related]
4. Total parenteral nutrition in patients with short bowel syndrome.
Ekema G; Milianti S; Boroni G
Minerva Pediatr; 2009 Jun; 61(3):283-91. PubMed ID: 19461572
[TBL] [Abstract][Full Text] [Related]
5. The use of Omegaven in treating parenteral nutrition-associated liver disease.
Park KT; Nespor C; Kerner J
J Perinatol; 2011 Apr; 31 Suppl 1():S57-60. PubMed ID: 21448206
[TBL] [Abstract][Full Text] [Related]
6. Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults.
Xu Z; Li Y; Wang J; Wu B; Li J
Clin Nutr; 2012 Apr; 31(2):217-23. PubMed ID: 22035955
[TBL] [Abstract][Full Text] [Related]
7. [Fish oil in prolonged parenteral nutrition in children--omega-3-fatty acids have a beneficial effect on the liver].
Strijbosch RA; van den Hoonaard TL; Olieman JF; Escher JC; Alwayn IP; Meijers-Ijsselstijn H
Ned Tijdschr Geneeskd; 2010; 154():A2003. PubMed ID: 20977797
[TBL] [Abstract][Full Text] [Related]
8. Nutritional management of infants with short bowel syndrome.
Wessel JJ; Kocoshis SA
Semin Perinatol; 2007 Apr; 31(2):104-11. PubMed ID: 17462495
[TBL] [Abstract][Full Text] [Related]
9. Management of short gut syndrome by omega 3 fatty acid infusion.
Jain SK; Pahwa M
Clin Nutr; 2007 Dec; 26(6):810. PubMed ID: 18029062
[No Abstract] [Full Text] [Related]
10. Parenteral but not enteral omega-3 fatty acids (Omegaven) modulate intestinal regrowth after massive small bowel resection in rats.
Sukhotnik I; Shany A; Bashenko Y; Hayari L; Chemodanov E; Mogilner J; Coran AG; Shaoul R
JPEN J Parenter Enteral Nutr; 2010; 34(5):503-12. PubMed ID: 20852178
[TBL] [Abstract][Full Text] [Related]
11. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (Omega-3 fatty acids).
Ekema G; Falchetti D; Boroni G; Tanca AR; Altana C; Righetti L; Ridella M; Gambarotti M; Berchich L
J Pediatr Surg; 2008 Jun; 43(6):1191-5. PubMed ID: 18558205
[TBL] [Abstract][Full Text] [Related]
12. Complications associated with total parenteral nutrition in infants with short bowel syndrome.
Nousia-Arvanitakis S; Angelopoulou-Sakadami N; Metroliou K
Hepatogastroenterology; 1992 Apr; 39(2):169-72. PubMed ID: 1353049
[TBL] [Abstract][Full Text] [Related]
13. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes.
Andorsky DJ; Lund DP; Lillehei CW; Jaksic T; Dicanzio J; Richardson DS; Collier SB; Lo C; Duggan C
J Pediatr; 2001 Jul; 139(1):27-33. PubMed ID: 11445790
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
[TBL] [Abstract][Full Text] [Related]
15. Intestinal adaptation in pediatric patients with short-bowel syndrome.
Wasa M; Takagi Y; Sando K; Harada T; Okada A
Eur J Pediatr Surg; 1999 Aug; 9(4):207-9. PubMed ID: 10532258
[TBL] [Abstract][Full Text] [Related]
16. [Use of fish oil lipid emulsions in hospitalized patients under 18 years old with abnormal results in liver tests associated with total parental nutrition].
Giraldo Villa A; Henao Roldan C; García Loboguerrero F; Martínez Volkmar MI; Contreras Ramírez MM; Ruiz Navas P;
Nutr Hosp; 2014 Apr; 29(4):844-51. PubMed ID: 24679026
[TBL] [Abstract][Full Text] [Related]
17. [Effect of the administration of cholecystokinin on the cholestasis associated with total parenteral nutrition in experimental short bowel].
García-Urkia N; Asensio AB; Cano A; Samprón N; García-Arenzana JM; Bachiller P; Aldazabal P; Eizaguirre I
Cir Pediatr; 2007 Jul; 20(3):180-2. PubMed ID: 18018748
[TBL] [Abstract][Full Text] [Related]
18. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.
Rollins MD; Scaife ER; Jackson WD; Meyers RL; Mulroy CW; Book LS
Nutr Clin Pract; 2010 Apr; 25(2):199-204. PubMed ID: 20413701
[TBL] [Abstract][Full Text] [Related]
19. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.
Gura KM; Duggan CP; Collier SB; Jennings RW; Folkman J; Bistrian BR; Puder M
Pediatrics; 2006 Jul; 118(1):e197-201. PubMed ID: 16818533
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Failure-Associated Liver Disease and Eicosapentaenoic Acid/Arachidonic Acid Ratio.
Miura W; Nagano N; Kato R; Okahashi A; Yoshikawa K; Ohashi K; Koshinaga T; Morioka I
Indian J Pediatr; 2019 Jun; 86(6):548-550. PubMed ID: 30761448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
